Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.35 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.35 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.35 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | DDO | Q99489 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.33 |
| ▸ | S100A4 | P26447 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8733810 | 0.78 | CA1 (0.43) | CA1CA2CA7CA9CYP19A1 | |
| SCHEMBL28350317 | 0.75 | CA1 (0.38) | CA1CA2CA7CA9 | |
| SCHEMBL14939430 | 0.73 | MAPT (0.62) | CA1CA2CA7CA9CYP19A1 | |
| SCHEMBL10716838 | 0.70 | MAOA (0.52) | CA1CA2CA7CA9AKR1A1 | |
| SCHEMBL13487412 | 0.70 | CA1 (0.52) | CA1CA2CA7CA9AKR1A1 | |
| SCHEMBL5866470 | 0.70 | CA1 (0.52) | CA1CA2CA7CA9AKR1A1 | |
| SCHEMBL9851539 | 0.69 | BACE1 (0.35) | CA1CA2CA7CA9SRD5A1 | |
| SCHEMBL28619081 | 0.69 | CA1 (0.40) | CA1CA2CA7CA9CYP19A1 | |
| SCHEMBL22129686 | 0.69 | CA1 (0.48) | CA1CA2CA7CA9AKR1A1 | |
| SCHEMBL8916299 | 0.69 | MAPT (0.54) | CA1CA2CA7CA9AKR1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2213662-B1 | AZAINDENOFLUORENEDIONE DERIVATIVE, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | IDEMITSU KOSAN CO (JP) | 2012-04-18 | — | — | EP | disclosed |
| US-8088901-B2 | Azaindenofluorenedione derivative, material for organic electroluminescence device and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-01-03 | — | — | US | disclosed |
| EP-2213662-A1 | AZAINDENOFLUORENEDIONE DERIVATIVE, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2010-08-04 | — | — | EP | disclosed |
| US-20090315022-A1 | AZAINDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090315022-A1 | AZAINDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | CYP19A1, HSD17B2, AZI2 | CA1 3005/4885CA2 3891/4885CA7 2139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.